DarshanTalks Podcast Podcast Por Darshan Kulkarni arte de portada

DarshanTalks Podcast

DarshanTalks Podcast

De: Darshan Kulkarni
Escúchala gratis

Welcome to DarshanTalks!

We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!

Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.

We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.

© 2026 DarshanTalks Podcast
Ciencia Ciencias Biológicas Ciencias Sociales
Episodios
  • 6 Categories of "Bulk Data" That Could Land You in Federal Court.
    Mar 27 2026

    Send us Fan Mail

    The DOJ just changed the rules of the game for the Life Sciences industry. As of January 2025, transferring "Bulk Sensitive Personal Data" to countries of concern—specifically China—is no longer just a compliance hurdle; it’s a potential federal violation. In this episode, Darshan Kulkarni breaks down the six categories of data you must protect immediately, from genomic data to precise geolocation. If you are handling safety data across borders, this is your mandatory executive briefing.

    Support the show

    www.kulkarnilawfirm.com

    Más Menos
    1 m
  • The Utah Experiment: The Dangerous New Frontier of AI Prescribing
    Mar 26 2026

    Send us Fan Mail

    Is your state "sandbox" a playground or a legal minefield? In this episode, Darshan Kulkarni—pharmacist and attorney—dissects the quiet movement of states like Utah allowing AI to manage and renew prescriptions. While the innovation is exciting, the federal government is watching closely.

    We break down the three massive risks facing life science companies and healthcare providers today:

    1. Clinical Logic Failures: Why a state sandbox can't fix bad AI medicine.
    2. The Liability Void: If the AI misses a symptom, who stands in court?
    3. The Supremacy Clause: Why state "waivers" don't protect you from the FDA.

    If you are navigating the intersection of health-tech and regulation, this is the practical take you need to stay compliant and protected.

    Support the show

    www.kulkarnilawfirm.com

    Más Menos
    2 m
  • Is Your DTC Program a Kickback Trap?
    Mar 23 2026

    Send us Fan Mail

    The OIG has officially shifted the goalposts for Direct-to-Consumer (DTC) and Direct-to-Patient (DTP) programs. For years, federal healthcare discounts were a "no-go zone," but a new dual-track strategy is emerging—if you know how to build the firewall. In this episode, Darshan Kulkarni breaks down the three core regulatory pillars required to bypass PBM middlemen without triggering federal anti-kickback statutes. We discuss the "one-year commitment" rule, the "seeding" trap, and why your current marketing strategy might be an unintentional red flag for regulators. If you are in Life Sciences commercialization, the "wait and see" approach is now your biggest liability.

    Support the show

    www.kulkarnilawfirm.com

    Más Menos
    3 m
Todavía no hay opiniones